What Is Fentanyl Citrate Solubility UK And Why Is Everyone Talking About It

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This article is planned for instructional and expert information purposes only. Fentanyl citrate is a Class A controlled compound in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formula should just be carried out by licensed specialists in controlled environments.

In the realm of pharmacology and clinical medicine, fentanyl citrate remains among the most powerful artificial opioids available. Due to its high efficacy and fast beginning of action, it is a foundation of pain management and anaesthesia in the UK's National Health Service (NHS) and personal health care sectors. Nevertheless, the medicinal efficiency of any drug is inherently connected to its physicochemical homes-- specifically its solubility.

Understanding the solubility of fentanyl citrate is crucial for pharmacists, researchers, and clinicians to make sure steady formulas, accurate dosing, and efficient drug shipment throughout different administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it possesses restricted solubility in aqueous environments. By reacting the base with citric acid, moving into the salt form (fentanyl citrate), the solubility in water is significantly improved. This makes it ideal for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is produced according to the standards set by the British Pharmacopoeia (BP). It typically appears as a white, crystalline powder or as granules that are odorless.

Key Physicochemical Properties

Home

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Approximately 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate differs significantly depending


on the solvent utilized and the ambient temperature level. In

a pharmaceutical setting, water is the main solvent of interest for injectables, however organic solvents are frequently used throughout the production of transdermal spots or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most frequently encountered as a 50 mcg/mL option for injection. At space temperature(approximately 20 ° C to 25 ° C), fentanyl

citrate is considered"moderately soluble"in water. Scientific literature normally suggests a solubility limitation of approximately 25 mg/mL in water at 25 ° C, which is more than adequate for basic clinical concentrations. Organic Solvent Solubility Fentanyl citrate exhibits different solubility in organic solvents, which is crucial for creating non-aqueous drug shipment systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Moderately Soluble ~ 25 mg/mL Methanol Freely Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Somewhat Soluble

<10 mg/mL Aspects Influencing Solubility and Stability The solubility of fentanyl citrate is not a fixed worth; it

is affected by several ecological and chemical factors that must be managed during intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate stays highly soluble in acidic to neutral services. The majority of UK-licensed fentanyl injections are buffered to a pH variety of

4.0 to 7.5. Alkaline Environments: If the pH of a service rises considerably above 7.5, there is a risk that the fentanyl


will transition back into its base type. Because the base

kind is substantially less soluble in water, this can result in"crashing out"or precipitation, which is exceptionally hazardous in an IV setting. 2. Temperature Effects Like many crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is helpful during the industrial dissolution procedure, it poses a danger throughout storage . If a saturated service is prepared at a heat and then cooled (such as during transportation in cold UK winters), the solute might take shape. 3. Existence of Other Ions(Common **Ion Effect )The existence of other citrate salts in the option can decrease the solubility of fentanyl citrate due to the common ion impact. This is a necessary consideration when blending fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The choice of buffer(e.g., sodium citrate or phosphate buffers)is

important in keeping a steady environment where the drug remains in its ionized, soluble form. Formulating for [Fentanyl Citrate Injection UK](https://hedgedoc.eclair.ec-lyon.fr/s/4RPNs8rx9) : British Pharmacopoeia Standards In the United Kingdom, medicinal items must comply with the British Pharmacopoeia(BP). The BP offers specific monographs for Fentanyl Citrate, ensuring purity, strength, and solubility requirements are fulfilled. Secret Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral options be clear and complimentary from visible particles. This is attained by making sure the concentration stays well listed below the saturation point. Sterility: Given the aqueous nature of the service, formulas should be

### decontaminated, normally

via autoclaving or purification, which can impact the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl formulations consist of Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH change). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the healthcare specialist? Avoiding Precipitation: Knowing that fentanyl is incompatible with extremely alkaline

**options(like thiopentone or some bicarbonate options

*   **)prevents the formation of precipitates that could cause embolic events. Optimizing Drug Delivery: In the development of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug should dissolve*   **rapidly in the small volume of saliva offered. Transdermal Flux: While spots count on the lipophilicity of the fentanyl base, the manufacture of these patches typically includes liquifying the citrate salt in an unpredictable solvent*   **before it is fertilized into the adhesive matrix. Storage and Handling Recommendations To keep the solubility and efficacy of fentanyl citrate products, the following guidelines are usually

            * * *

            followed in British medical settings: Temperature
            -------------------------------------------------

            Control: Store at controlled space temperature level (15 ° C to 25 ° C). Avoid freezing, as this can lead to irreversible precipitation in**certain formulas. Light** Protection: Fentanyl citrate is rather light-sensitive. Aqueous solutions should be kept in amber glass or nontransparent product packaging. Managing Potency: Because of its high solubility and strength, unexpected skin contact*   **with concentrated options** can result in systemic absorption. Professional PPE is obligatory. Frequently Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, considerably.
            *   **The citrate salt is created specifically to increase liquid solubility, making it suitable for injections. The base form is extremely lipophilic and is generally used in the internal layers of transdermal patches. Does the UK BP(British Pharmacopoeia)vary

                from the USP relating to solubility? The general

                solubility profiles are identical as they describe the same chemical entity. However, the specific screening methods and the prioritized solvents for pureness screening might differ

                *   **slightly in between the BP** and the United States Pharmacopeia (USP). Can I mix fentanyl citrate with saline? Yes. Fentanyl citrate is suitable with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents used in UK hospitals. What occurs if a fentanyl service ends up being cloudy? If an option of fentanyl citrate appears cloudy or includes** crystals, it needs to be disposed of. This shows that the drug has sped up out of the service, either due to pH modifications, temperature level shifts, or contamination.

                * * *

                Why is citric acid used specifically?
                -------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade natural acid. It forms a stable salt with fentanyl that offers a balance of high water solubility and suitable pH for human tissue. Fentanyl citrate is a crucial pharmacological tool in the UK, however its safety and efficacy are predicated on

                ### its chemical stability. Solubility is possibly the most critical factor in this regard

                . By maintaining an optimal pH, choosing the proper solvents, and sticking to British Pharmacopoeia standards, the pharmaceutical industry guarantees that this powerful analgesic stays a trustworthy alternative for patient care.

                ### For clinicians, the takeaway is simple: always validate compatibility before mixing and ensure storage conditions are strictly satisfied to avoid the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 26 May 2026 00:44 UTC

Views: 1